Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway.

Cancer Research
Margaret A ParkPaul Dent

Abstract

The targeted therapeutics sorafenib and vorinostat interact in a synergistic fashion to kill carcinoma cells by activating CD95, and this drug combination is entering phase I evaluation. In this study, we determined how CD95 is activated by treatment with this drug combination. Low doses of sorafenib and vorinostat, but not the individual drugs, rapidly increased reactive oxygen species (ROS), Ca(2+), and ceramide levels in gastrointestinal tumor cells. The production of ROS was reduced in Rho zero cells. Quenching ROS blocked drug-induced CD95 surface localization and apoptosis. ROS generation, CD95 activation, and cell killing was also blocked by quenching of induced Ca(2+) levels or by inhibition of PP2A. Inhibition of acidic sphingomyelinase or de novo ceramide generation blocked the induction of ROS; however, combined inhibition of both acidic sphingomyelinase and de novo ceramide generation was required to block the induction of Ca(2+). Quenching of ROS did not affect drug-induced ceramide/dihydro-ceramide levels, whereas quenching of Ca(2+) reduced the ceramide increase. Sorafenib and vorinostat treatment radiosensitized liver and pancreatic cancer cells, an effect that was suppressed by quenching ROS or knockdown of LAS...Continue Reading

References

Apr 17, 2001·Experimental Cell Research·P D GregoryW Hörz
Jun 7, 2003·Nature Cell Biology·Lindsey A AllanPaul R Clarke
Aug 7, 2003·Current Opinion in Pharmacology·Paul A MarksVictoria M Richon
Aug 30, 2003·Oncogene·Paul DentSteven Grant
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven Grant, Paul Dent
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Purva BaliKapil Bhalla
Mar 1, 2006·Expert Opinion on Pharmacotherapy·Brian I Rini
Jun 24, 2006·The Journal of Biological Chemistry·Yael Pewzner-JungAnthony H Futerman
Feb 13, 2007·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·L David WiseJanet S Kerr
Mar 17, 2007·Molecular Cancer Therapeutics·Kristoffer ValeriePaul Dent
May 12, 2007·Expert Review of Anticancer Therapy·Keith T Flaherty
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Girija DasmahapatraSteven Grant
Jul 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yu Fang WangPeter Hersey
Sep 19, 2007·Methods in Enzymology·Roland Reinehr, Dieter Häussinger
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guo ZhangPaul Dent
Nov 26, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Archana MukhopadhyayBesim Ogretmen
Jan 10, 2009·Science·Joanna WegrzynAndrew C Larner
Jun 11, 2009·Journal of the National Cancer Institute·Karl Y BilimoriaUNKNOWN Pancreatic Cancer Quality Indicator Development Expert Panel, American College of Surgeons

❮ Previous
Next ❯

Citations

Dec 22, 2011·Apoptosis : an International Journal on Programmed Cell Death·Jiin-Haur ChuangPei-Wen Wang
May 4, 2013·The Lancet Oncology·Danilo Perrotti, Paolo Neviani
Dec 14, 2012·Nature Reviews. Cancer·Samy A F Morad, Myles C Cabot
Jul 28, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sahar A SaddoughiBesim Ogretmen
Dec 25, 2013·Neurotoxicity Research·Joanna Jakubowicz-GilWojciech Rzeski
Mar 25, 2015·Cancer Biology & Therapy·Nichola CruickshanksPaul Dent
Dec 7, 2013·Cancer Biology & Therapy·Paul Dent
Mar 13, 2012·Cancer Biology & Therapy·Yong TangPaul Dent
Feb 24, 2015·Apoptosis : an International Journal on Programmed Cell Death·Sehamuddin GaladariFaisal Thayyullathil
Jul 6, 2016·Frontiers in Oncology·Mehrad TavallaiPaul Dent
Jul 10, 2012·Journal of Dermatological Science·Glady Hazitha SamuelMaria Trojanowska
Oct 19, 2016·Clinical Epigenetics·Angel R de Lera, A Ganesan
Feb 24, 2015·Journal of Cellular Physiology·Mehrad TavallaiPaul Dent
Jun 21, 2018·Cancer Biology & Therapy·Laurence BoothPaul Dent
Nov 28, 2018·Nature Reviews. Genetics·María Berdasco, Manel Esteller
Oct 11, 2014·Journal of Cellular Physiology·Laurence BoothPaul Dent
Apr 4, 2015·The Journal of Biological Chemistry·Tejas S TirodkarChristina Voelkel-Johnson
Aug 26, 2017·Future Medicinal Chemistry·Ella LinehamSimon J Morley
Apr 21, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Daniel CanalsYusuf A Hannun
May 24, 2016·Oncotarget·Andrew PoklepovicPaul Dent
Nov 16, 2017·Oncotarget·Laurence BoothPaul Dent
Aug 26, 2014·Biological Chemistry·Harald Wajant
Mar 31, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dafeng YangKebin Liu
Jan 14, 2012·Expert Opinion on Therapeutic Targets·María Villa-Morales, José Fernández-Piqueras
Apr 5, 2020·International Journal of Molecular Sciences·Katja JakobiGeorgios Grammatikos
Jul 8, 2017·Cancer Biology & Therapy·E Ramsay CampChristina Voelkel-Johnson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.